These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 24001328)
1. Identification of new Fyn kinase inhibitors using a FLAP-based approach. Poli G; Tuccinardi T; Rizzolio F; Caligiuri I; Botta L; Granchi C; Ortore G; Minutolo F; Schenone S; Martinelli A J Chem Inf Model; 2013 Oct; 53(10):2538-47. PubMed ID: 24001328 [TBL] [Abstract][Full Text] [Related]
2. Studies on the ATP Binding Site of Fyn Kinase for the Identification of New Inhibitors and Their Evaluation as Potential Agents against Tauopathies and Tumors. Tintori C; La Sala G; Vignaroli G; Botta L; Fallacara AL; Falchi F; Radi M; Zamperini C; Dreassi E; Dello Iacono L; Orioli D; Biamonti G; Garbelli M; Lossani A; Gasparrini F; Tuccinardi T; Laurenzana I; Angelucci A; Maga G; Schenone S; Brullo C; Musumeci F; Desogus A; Crespan E; Botta M J Med Chem; 2015 Jun; 58(11):4590-609. PubMed ID: 25923950 [TBL] [Abstract][Full Text] [Related]
3. Structure-based grafting and identification of kinase-inhibitors to target mTOR signaling pathway as potential therapeutics for glioblastoma. Cui YH; Chen J; Xu T; Tian HL Comput Biol Chem; 2015 Feb; 54():57-65. PubMed ID: 25625417 [TBL] [Abstract][Full Text] [Related]
4. Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor. Chen D; Ranganathan A; IJzerman AP; Siegal G; Carlsson J J Chem Inf Model; 2013 Oct; 53(10):2701-14. PubMed ID: 23971943 [TBL] [Abstract][Full Text] [Related]
5. Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitors. Poli G; Lapillo M; Granchi C; Caciolla J; Mouawad N; Caligiuri I; Rizzolio F; Langer T; Minutolo F; Tuccinardi T J Enzyme Inhib Med Chem; 2018 Dec; 33(1):956-961. PubMed ID: 29747534 [TBL] [Abstract][Full Text] [Related]
6. Discovery of novel tubulin inhibitors via structure-based hierarchical virtual screening. Cao R; Liu M; Yin M; Liu Q; Wang Y; Huang N J Chem Inf Model; 2012 Oct; 52(10):2730-40. PubMed ID: 22992059 [TBL] [Abstract][Full Text] [Related]
7. Ligand efficiency based approach for efficient virtual screening of compound libraries. Ke YY; Coumar MS; Shiao HY; Wang WC; Chen CW; Song JS; Chen CH; Lin WH; Wu SH; Hsu JT; Chang CM; Hsieh HP Eur J Med Chem; 2014 Aug; 83():226-35. PubMed ID: 24960626 [TBL] [Abstract][Full Text] [Related]
8. Structure-based virtual screening of MT2 melatonin receptor: influence of template choice and structural refinement. Pala D; Beuming T; Sherman W; Lodola A; Rivara S; Mor M J Chem Inf Model; 2013 Apr; 53(4):821-35. PubMed ID: 23541165 [TBL] [Abstract][Full Text] [Related]
9. Computational studies of epidermal growth factor receptor: docking reliability, three-dimensional quantitative structure-activity relationship analysis, and virtual screening studies. La Motta C; Sartini S; Tuccinardi T; Nerini E; Da Settimo F; Martinelli A J Med Chem; 2009 Feb; 52(4):964-75. PubMed ID: 19170633 [TBL] [Abstract][Full Text] [Related]
10. Molecular dynamics-based virtual screening: accelerating the drug discovery process by high-performance computing. Ge H; Wang Y; Li C; Chen N; Xie Y; Xu M; He Y; Gu X; Wu R; Gu Q; Zeng L; Xu J J Chem Inf Model; 2013 Oct; 53(10):2757-64. PubMed ID: 24001302 [TBL] [Abstract][Full Text] [Related]
11. Fyn kinase in brain diseases and cancer: the search for inhibitors. Schenone S; Brullo C; Musumeci F; Biava M; Falchi F; Botta M Curr Med Chem; 2011; 18(19):2921-42. PubMed ID: 21651487 [TBL] [Abstract][Full Text] [Related]
12. Pharmacophore based virtual screening, molecular docking studies to design potent heat shock protein 90 inhibitors. Sakkiah S; Thangapandian S; John S; Lee KW Eur J Med Chem; 2011 Jul; 46(7):2937-47. PubMed ID: 21531051 [TBL] [Abstract][Full Text] [Related]
13. Identification of sumoylation activating enzyme 1 inhibitors by structure-based virtual screening. Kumar A; Ito A; Hirohama M; Yoshida M; Zhang KY J Chem Inf Model; 2013 Apr; 53(4):809-20. PubMed ID: 23544417 [TBL] [Abstract][Full Text] [Related]
15. Identification of novel inhibitors of tropomyosin-related kinase A through the structure-based virtual screening with homology-modeled protein structure. Park H; Chi O; Kim J; Hong S J Chem Inf Model; 2011 Nov; 51(11):2986-93. PubMed ID: 22017333 [TBL] [Abstract][Full Text] [Related]
17. Protein-ligand-based pharmacophores: generation and utility assessment in computational ligand profiling. Meslamani J; Li J; Sutter J; Stevens A; Bertrand HO; Rognan D J Chem Inf Model; 2012 Apr; 52(4):943-55. PubMed ID: 22480372 [TBL] [Abstract][Full Text] [Related]
18. In silico screening of Fyn kinase inhibitors using classification-based QSAR model, molecular docking, molecular dynamics and ADME study. Hang NT; Anh TDH; Thanh LN; Anh NV; Van Phuong N Mol Divers; 2024 Aug; 28(4):2217-2228. PubMed ID: 38886315 [TBL] [Abstract][Full Text] [Related]
19. Combining ligand- and structure-based approaches for the discovery of new inhibitors of the EPHA2-ephrin-A1 interaction. Pala D; Castelli R; Incerti M; Russo S; Tognolini M; Giorgio C; Hassan-Mohamed I; Zanotti I; Vacondio F; Rivara S; Mor M; Lodola A J Chem Inf Model; 2014 Oct; 54(10):2621-6. PubMed ID: 25289483 [TBL] [Abstract][Full Text] [Related]
20. Structure of human Fyn kinase domain complexed with staurosporine. Kinoshita T; Matsubara M; Ishiguro H; Okita K; Tada T Biochem Biophys Res Commun; 2006 Aug; 346(3):840-4. PubMed ID: 16782058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]